<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01265771</url>
  </required_header>
  <id_info>
    <org_study_id>UDAPOIG.01.03.01-00-068/09-00B</org_study_id>
    <nct_id>NCT01265771</nct_id>
  </id_info>
  <brief_title>Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions</brief_title>
  <acronym>TELEMARC2</acronym>
  <official_title>Optimizing Diagnostics And Therapy Of Arrhythmia And Syncope Events Using Intelligent Telemetric Solutions. Diagnostics Of Arrhythmia In Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess efficacy of prolonged Full Disclosure
      electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology
      to diagnose arrhythmia in comparison with standard diagnostic procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Irregular and/or rapid beating of the heart called heart palpitations can occur in
      individuals without heart disease and the reasons for their palpitations are unknown.
      Together with heart palpitations silent arrhythmia may be present that could lead to serious
      complications (eg. stroke). In others, palpitations result from heart rhythm disturbances,
      sometimes life threatening. Standard diagnostic methods such as 24 hours Holter
      electrocardiogram (ECG) monitoring or Event Holter do not guarantee early diagnosis of the
      arrhythmia. Prolonged heart rhythm recording and analysis using an automatic full disclosure
      telemetric device can increase probability of arrhythmia diagnosis and early administration
      of applicable treatment. Study patients will be diagnosed using standard Holter ECG
      monitoring, Event Holter or 30 days telemetric ECG monitoring. Efficacy of telemetric
      monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the
      standard Holter monitoring and Event Holter
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recording of symptomatic or life threatening arrhythmia event</measure>
    <time_frame>within 30 days since the start of monitoring</time_frame>
    <description>ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 30 days. Patients in the control group will have standard ECG Holter monitoring repeated twice</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of silent (asymptomatic) arrhythmia event</measure>
    <time_frame>within 30 days since the start of monitoring</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrence</measure>
    <time_frame>within 30 days since the start of monitoring</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Arrhythmia</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Telemetry ordered by a Cardiologist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>24 hours standard Holter monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemetry ordered by a Pediatrician</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prolonged telemetric Full Disclosure ECG recording.</intervention_name>
    <description>Thirty days Telemetric Full Disclosure ECG monitoring; subsequently analyzed in the Event Holter monitoring mode</description>
    <arm_group_label>Telemetry ordered by a Cardiologist</arm_group_label>
    <arm_group_label>Telemetry ordered by a Pediatrician</arm_group_label>
    <other_name>Pocket ECG, Medicalgorithmics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repeated 24 hours ECG Holter monitoring</intervention_name>
    <description>Repeated 24 hours ECG Holter monitoring</description>
    <arm_group_label>24 hours standard Holter monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of symptoms that can be potentially caused by cardiac arrhythmia occuring at
             least 4 times a year

          -  Ability to operate the telemetric device at home

          -  Informed consent undersigned by the parents

          -  Informed consent undersigned by the child if over 16 years of age

        Exclusion Criteria:

          -  Previously recorded tachycardia evidence

          -  Wolff Parkinson White syndrome

          -  Inability to operate the telemetric device at home

          -  Inability to comply with the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukasz Szumowski, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Cardiology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katarzyna Bieganowska, Prof. MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Memorial Health Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katarzyna Bieganowska, Prof. MD PhD</last_name>
    <email>kbieganowska@wp.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Miszczak-Knecht, MD PhD</last_name>
    <email>mmknecht@neostrada.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Warsaw Department of Pediatric Cardiology and General Pediatrics</name>
      <address>
        <city>Warsaw</city>
        <zip>00-576</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bożena Werner, MD PhD</last_name>
      <phone>(+48 22) 629 83 17</phone>
      <email>kardiologia@litewska.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Bożena Werner, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Florianczyk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-620</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukasz Szumowski, Prof</last_name>
      <email>lszumowski@ikard.pl</email>
    </contact>
    <investigator>
      <last_name>Lukasz Szumowski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zbigniew Jedynak, dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Memmorial Health Institute</name>
      <address>
        <city>Warsaw</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Bieganowska, Prof. MD PhD</last_name>
      <email>kbieganowska@wp.pl</email>
    </contact>
    <contact_backup>
      <last_name>Maria Miszczak-Knecht, MD PhD</last_name>
      <email>mmknecht@neostrada.pl</email>
    </contact_backup>
    <investigator>
      <last_name>Katarzyna Bieganowska, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Miszczak-Knecht, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2010</study_first_posted>
  <last_update_submitted>December 2, 2011</last_update_submitted>
  <last_update_submitted_qc>December 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Lukasz Szumowski MD PhD</name_title>
    <organization>Institute of Cardiology, Warsaw</organization>
  </responsible_party>
  <keyword>Arrhythmia</keyword>
  <keyword>Children</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

